publicationMetadata:
  pmid: "PMID:33273014"
  title: "mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition."
  queryType: "bench"
  publicationType: "Lab Research"
  publicationTypeConfidence: 1.0
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Lab Research â†’ antibodies, cell lines, animal models, genetic reagents, computational tools, organoids, PDX
    This is a molecular biology study using cell lines, drug treatments, and molecular assays.
    Expected tools include cell lines, antibodies, genetic reagents, and computational analysis tools.
  overallAssessment: |
    This is a laboratory research study investigating molecular mechanisms in NF2-deficient meningioma cells.
    The study uses multiple cell lines, drug treatments, molecular biology techniques, and computational analysis.
    High likelihood of containing genuine research tools including cell lines, antibodies, and analysis software.

toolValidations: []

potentiallyMissedTools:
  - toolName: "Ben-Men-1"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "...NF2-null human arachnoidal cells (ACs) and the MN cell line Ben-Men-1, particularly neuregulin-1/heregulin..."
    whyMissed: "Cell line name not caught by initial mining patterns"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "AC-CRISPR"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "...Human cell lines included an NF2-null immortalized MN line Ben-Men-1, NF2 AC-CRISPR, and two independent human primary MN..."
    whyMissed: "CRISPR-modified cell line not caught by patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "MN1-LF"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "...we generated an immortalized human MN line, MN1-LF from an independent NF2-null human primary MN cell line..."
    whyMissed: "Custom cell line name not in standard patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "CSCW2"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "...NF2 (isoform 1, NCBI accession # NM_000268) cloned into the lentiviral vector CSCW2 followed by packaging..."
    whyMissed: "Lentiviral vector name not caught"
    confidence: 0.85
    shouldBeAdded: Yes

  - toolName: "TRIzol reagent"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "...RNA was isolated from all MN-relevant lines using TRIzol reagent (15596026, ThermoFisher Scientific)..."
    whyMissed: "Commercial reagent with catalog number not caught"
    confidence: 0.8
    shouldBeAdded: Yes

  - toolName: "STAR"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "...Sequence reads were aligned to human reference genome Ensembl GRCh37 (v.75), using STAR (v. 2.5.2a)..."
    whyMissed: "Bioinformatics alignment tool with version not caught"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "edgeR"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "...Differentially expressed genes in pair-wise comparisons were identified by edgeR's quasi-likelihood F test (v. 3.18.1)..."
    whyMissed: "R package for differential expression analysis not caught"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "SynergyFinder"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "...Synergy scores were generated using the web-based SynergyFinder application (https://synergyfinder.fimm.fi/)..."
    whyMissed: "Web-based analysis tool with URL not caught"
    confidence: 0.85
    shouldBeAdded: Yes

  - toolName: "anti-ERBB3 Y1197"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "...Antibodies recognizing ERRB3 Y1197, ERBB3, EPHA2 S897, NDRG1 T346, Akt S473, Akt T308..."
    whyMissed: "Phospho-specific antibody not caught by patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "anti-NF2/merlin polyclonal antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "...Anti-NF2/merlin polyclonal antibody has been previously described..."
    whyMissed: "Custom antibody description not caught"
    confidence: 0.85
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "naming_convention"
    pattern: "[A-Z]{2,4}-[A-Z][a-z]+-[0-9]+"
    toolType: "cell_line"
    examples: ["Ben-Men-1", "MN1-LF"]
    reasoning: "Captures cell line naming convention with tissue/disease prefix and numerical suffix"

  - patternType: "context_phrase"
    pattern: "lentiviral vector [A-Z0-9]+"
    toolType: "genetic_reagent"
    examples: ["lentiviral vector CSCW2"]
    reasoning: "Identifies viral vectors used for genetic manipulation"

  - patternType: "vendor_indicator"
    pattern: "\\b[A-Za-z]+ reagent \\([0-9]+, [A-Za-z ]+\\)"
    toolType: "genetic_reagent"
    examples: ["TRIzol reagent (15596026, ThermoFisher Scientific)"]
    reasoning: "Captures commercial reagents with catalog numbers and vendor information"

  - patternType: "term"
    pattern: "anti-[A-Z0-9/]+ (Y|S|T)[0-9]+"
    toolType: "antibody"
    examples: ["anti-ERBB3 Y1197", "anti-EPHA2 S897"]
    reasoning: "Identifies phospho-specific antibodies with target and phosphorylation site"

  - patternType: "context_phrase"
    pattern: "using [A-Z]+ \\(v\\. [0-9\\.]+[a-z]*\\)"
    toolType: "computational_tool"
    examples: ["using STAR (v. 2.5.2a)", "using edgeR (v. 3.18.1)"]
    reasoning: "Captures software tools with version numbers in analysis context"

observations: []

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 10
  newPatternsCount: 5
  observationsExtracted: 0
  observationsByType: {}
  majorIssuesFound: |
    - No tools were initially mined despite this being a comprehensive lab research study
    - Multiple cell lines, antibodies, reagents, and computational tools are clearly present
    - Mining patterns appear to have significant gaps for this type of molecular biology research
  recommendations: |
    This publication contains numerous genuine research tools that were completely missed by initial mining.
    The study uses multiple cell lines (Ben-Men-1, AC-CRISPR, MN1-LF), commercial reagents with catalog numbers,
    computational analysis tools with versions, and specific antibodies. All potentially missed tools should be added.
    The suggested patterns would significantly improve mining coverage for similar molecular biology studies.
    No observations were extracted since no tools were initially validated, but this study likely contains
    valuable phenotypic and molecular observations that could be captured once tools are properly identified.